Sign inCreate account

Report workspace tools

NCT05914818COMPLETEDanonymous

Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

Sponsor

Source record

MarsiBionics

Phase

Source record

Proof of Concept (Phase 0)

Modality

AI-normalized

medical device

Target

AI-normalized

Pediatric and Adolescent EXPLORER V2 Exoskeleton

Indication / condition

AI-normalized

Cerebral Palsy

Intervention

Source record

EXPLORER V2

Source & freshness

Source record

NCT ID

NCT05914818

Original source

ClinicalTrials.gov

Source last updated

Nov 03, 2023

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT05914818

Title

Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

Sponsor

MarsiBionics

Status

COMPLETED

Phase

Proof of Concept (Phase 0)

Condition raw

Cerebral Palsy

Condition normalized

Cerebral Palsy

Modality raw

Cerebral Palsy

Modality normalized

medical device

Target raw

Pediatric and Adolescent EXPLORER V2 Exoskeleton

Target normalized

Pediatric and Adolescent EXPLORER V2 Exoskeleton

Interventions

EXPLORER V2

Public preview

Source record

MarsiBionics is developing the EXPLORER V2 exoskeleton aimed at assisting children with neurological and neuromuscular diseases in their daily activities. This clinical trial assesses the usability and safety of the device in real-world settings, which could enhance rehabilitation outcomes and market acceptance.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT05914818

Status

COMPLETED

Phase

Proof of Concept (Phase 0)

Sponsor

MarsiBionics

Executive brief

Investment-Ready Snapshot

MarsiBionics is developing the EXPLORER V2 exoskeleton aimed at assisting children with neurological and neuromuscular diseases in their daily activities. This clinical trial assesses the usability and safety of the device in real-world settings, which could enhance rehabilitation outcomes and market acceptance.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedNov 03, 2023
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT05914818

Indication

Cerebral Palsy

Modality

medical device

Target

Pediatric and Adolescent EXPLORER V2 Exoskeleton

Intervention

EXPLORER V2

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.